4.8 Article

canSAR: an integrated cancer public translational research and drug discovery resource

期刊

NUCLEIC ACIDS RESEARCH
卷 40, 期 D1, 页码 D947-D956

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkr881

关键词

-

资金

  1. Cancer Research UK [C309/A8274]
  2. NHS
  3. Cancer Research UK [11566] Funding Source: researchfish

向作者/读者索取更多资源

canSAR is a fully integrated cancer research and drug discovery resource developed to utilize the growing publicly available biological annotation, chemical screening, RNA interference screening, expression, amplification and 3D structural data. Scientists can, in a single place, rapidly identify biological annotation of a target, its structural characterization, expression levels and protein interaction data, as well as suitable cell lines for experiments, potential tool compounds and similarity to known drug targets. canSAR has, from the outset, been completely use-case driven which has dramatically influenced the design of the back-end and the functionality provided through the interfaces. The Web interface at http://cansar.icr.ac.uk provides flexible, multipoint entry into canSAR. This allows easy access to the multidisciplinary data within, including target and compound synopses, bioactivity views and expert tools for chemogenomic, expression and protein interaction network data.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据